E-LIB Suche - Ergebnisse für: Vekemans, Marie-Christiane

1

P-435 Acquired angioedema, a rare manifestation of MGCS:

Leman, Quentin ; Georgery, Hélène ; Jadot, Gaspard...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S280-S281 , 2023

Link: https://doi.org/10.1016/..

2

The European Pesticides Harmonised Risk Indicator HRI_1: A ..:

Vekemans, Marie-Cécile ; Marchand, Patrice A.
European Journal of Risk Regulation. 15 (2023) 1 - p. 153-178 , 2023

Link: https://doi.org/10.1017/..

3

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN IN..:

Groen, Kaz ; Stege, Claudia ; Nasserinejad, Kazem...
HemaSphere. 7 (2023) S3 - p. e25266f8 , 2023

Link: https://doi.org/10.1097/..

4

P-247 Efficacy and safety of linvoseltamab 200 mg in patien..:

Dhodapkar, Madhav ; Bumma, Naresh ; Richter, Joshua...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S172 , 2023

Link: https://doi.org/10.1016/..

5

P-427 Smoldering multiple myeloma associated with a acquire..:

Iarossi, Michael ; Vekemans, Marie-Christiane Madeleine ; Weynants, Nicolas.
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S276 , 2023

Link: https://doi.org/10.1016/..

6

P-244 Teclistamab versus Belgian real-world clinical practi..:

Delforge, Michel ; Anguille, Sébastien ; Depaus, Julien...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S170 , 2023

Link: https://doi.org/10.1016/..

7

Ixazomib, daratumumab and low-dose dexamethasone in interme..:

Groen, Kaz ; Stege, Claudia A.M. ; Nasserinejad, Kazem...
eClinicalMedicine. 63 (2023) - p. 102167 , 2023

Link: https://doi.org/10.1016/..

8

Ixazomib, daratumumab and low-dose dexamethasone in interme..:

Groen, Kaz ; Stege, Claudia A.M ; Nasserinejad, Kazem...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481174/. , 2023

Link: http://www.ncbi.nlm.nih...

9

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN IN..:

Kaz Groen ; Claudia Stege ; Kazem Nasserinejad...
http://journals.lww.com/10.1097/01.HS9.0000970412.25266.f8. , 2023

Link: https://doi.org/10.1097/..

10

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN IN..:

Groen, Kaz ; Stege, Claudia ; Nasserinejad, Kazem...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430933/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Ixazomib, daratumumab and low-dose dexamethasone in interme..:

Kaz Groen ; Claudia A.M. Stege ; Kazem Nasserinejad...
http://www.sciencedirect.com/science/article/pii/S2589537023003449. , 2023

Link: https://doi.org/10.1016/..

12

Ixazomib, daratumumab and low-dose dexamethasone in interme..:

Groen, Kaz ; Stege, Claudia A.M ; Nasserinejad, Kazem...
https://research.rug.nl/en/publications/cc6f1e97-011c-45da-a8e8-0d7c882373ec. , 2023

Link: https://hdl.handle.net/1..

13

Whole-body MRI in oncology: can a single anatomic T2 Dixon ..:

Chiabai, Ophelye ; Van Nieuwenhove, Sandy ; Vekemans, Marie-Christiane...
European Radiology. 33 (2022) 1 - p. 244-257 , 2022

Link: https://doi.org/10.1007/..

14

AML-234 Prognostic Value of FLT3-ITD Residual Disease in Ac..:

Vonk, Christian ; Grob, Tim ; Sanders, Mathijs...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S227 , 2022

Link: https://doi.org/10.1016/..

15

Treatments in Patients with Relapsed/Refractory Multiple My..:

Delforge, Michel ; Vekemans, Marie-Christiane ; Anguille, Sébastien...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S6-S7 , 2022

Link: https://doi.org/10.1016/..